Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
NCT02329769
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG:
PRO044 SC 6 mg/kg
DRUG:
PRO044 IV 6 mg/kg
DRUG:
PRO044 IV 9 mg/kg
Sponsor
BioMarin Pharmaceutical